Ranked #1 Children's Hospital by U.S. News & World Report
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
Boston Children’s Hospital is a world leader in pediatric respiratory diseases, including interstitial lung disease (ILD or chILD). We specialize in innovative, family-centered care that supports you at every step on your child’s journey to health.
Our Interstitial Lung Disease Program is a part of the Children's Interstitial Lung Disease Research Network (chILDRN) associated with the Children's Interstitial Lung Disease (chILD) Foundation. Learn more about our research.
Interstitial lung disease is not a single disease; it includes many distinct chronic diffuse lung disorders, which fall under the umbrella diagnosis of Children’s Interstitial Lung Disease. Individually the disorders are rare, but collectively they are not. Symptoms can range from mild to severe and have different treatments and outcomes. Some of the disorders are specific to the lungs while others are pulmonary manifestations of systemic disorders. Learn more about ILD.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”